A case study details the care of a patient who had already lost vision in one eye from a similar issue.
Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410
Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches
Richard Rosen, MD, honored with distinguished award from ASRS
(EyePod) From idea to impact: Navigating ophthalmic innovation
ASRS 2024: TEASE-3 study data shows progression stalled in early-stage Stargardt disease patients treated with gildeuretinol
ASRS 2024: Retina surgeon dexterity affected by external exposures